Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Cellular Senescence and Frailty
Author(s): Jorge D Erusalimsky Added: 1 week ago

Prevention & Chronic Conditions

CV Disease in Special Populations
Immune Cell Traits and Heart Failure: A Mendelian Randomisation Study
Author(s): Wei Gao , Hui Wang , Jian-long Wang , et al Added: 5 months ago

Demographic

Heart Failure
AHA Scientific Sessions 2025 Late-Breaking and Featured Science Collection
Author(s): Nicolas M Van Mieghem Added: 5 months ago
Stay at the forefront of cardiovascular medicine with our comprehensive video collection from the American Heart Association's Scientific Sessions 2025. Access expert analysis of the most impactful late-breaking trials and featured science shaping clinical practice.Late-Breaker Discussions: Watch Dr Harriette Van Spall break down pivotal clinical trial data and explore its implications for… View more

Intervention

Cardiovascular Renal Metabolic
TTR Therapies Show Delayed Mortality Benefit in ATTR-CM
Added: 1 month ago Source:  Radcliffe Cardiology
Therapies for transthyretin amyloidosis with cardiomyopathy (ATTR-CM), including transthyretin (TTR) stabilisers and silencers, have demonstrated a mortality benefit in randomised trials. However, the timing of this benefit has been a subject of debate. A new analysis of three major outcomes trials has evaluated this time course, revealing a consistent pattern across different treatments… View more

Heart Failure
Delayed ATTR-CM Diagnosis Common in HF Patients
Added: 1 month ago Source:  Radcliffe Cardiology
A new study has revealed significant delays in the diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM) following an initial diagnosis of heart failure (HF), with the median time to diagnosis exceeding one year.¹ Timely identification of ATTR-CM is critical to reduce morbidity and mortality, as effective treatments are available.²MethodologyThis retrospective cohort study analysed data… View more

Heart Failure
e-SPACE Heart Failure 2024
Author(s): Maria Rosa Costanzo , JoAnn Lindenfeld , Nicolas Girerd , et al Added: 1 year ago
Translational Medicine Academy (TMA) in partnership with Radcliffe Cardiology were delighted to announce the return of e-SPACE Heart Failure held on the 18-19 October 2024.e-SPACE Heart Failure 2024 once again provided top-tier free virtual education and optimised geographical reach whilst delivering both global and regional insight. The thoughtfully curated programme explored how leading experts… View more

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
GLP-1RA in Different HFpEF Phenotypes
Author(s): Aleksandra Bykova , Maria Serova , Maria Chashkina , et al Added: 1 year ago

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
Hyperkalaemia in Acute Heart Failure: An Asian Population Study
Author(s): Wy Jin Quah , Maizatu Akma Sulong , Ghazali Ahmad , et al Added: 9 months ago

Cardiovascular Renal Metabolic

Heart Failure
Mineralocorticoid Receptor Antagonists in Heart Failure
Author(s): Rishi Sethi , Pravesh Vishwakarma , Akshyaya Pradhan Added: 1 year ago

MI/ACS

Heart Failure
Late breaking Clinical Trial Data Addressing Cardiovascular Outcomes in Patients with Diabetes presented at American College of Cardiology Congress
Added: 2 years ago Source:  Radcliffe Cardiology
AUTHOR: Greg GuilloryTwo late-breaking clinical trials addressing cardiovascular outcomes in patients with diabetes were presented this week at the American College of Cardiology meeting in Atlanta, USA. One of these trials looked at the effects of the hyperactivation of the polyol pathway on diabetic cardiomyopathy (DbCM) and the other the effects of chelation therapy in patients with diabetes… View more

Cardiovascular Renal Metabolic

Heart Failure